(Q39869117)

English

Thalidomide suppressed the growth of 4T1 cells into solid tumors in Balb/c mice in a combination therapy with the oncolytic fusogenic HSV-1 OncdSyn

scientific article published on 24 March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Thalidomide suppressed the growth of 4T1 cells into solid tumors in Balb/c mice in a combination therapy with the oncolytic fusogenic HSV-1 OncdSyn (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

0 references

Herpes simplex virus type 1

1 reference

based on heuristic

inferred from title

Konstantin G Kousoulas

5

object named as

Konstantin G Kousoulas

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

author name string

Anna Israyelyan

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Edward John Shannon

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Abolghasem Baghian

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Michael T Kearney

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

publication date

24 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

64

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1201-1210

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

https://scigraph.springernature.com/pub.10.1007/s00280-009-0987-8

0 references

Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity

1 reference

https://api.crossref.org/works/10.1007%2FS00280-009-0987-8

21 January 2018

Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid

1 reference

https://api.crossref.org/works/10.1007%2FS00280-009-0987-8

21 January 2018

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FS00280-009-0987-8

21 January 2018

Vascular disrupting agents: a new class of drug in cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-009-0987-8

21 January 2018

In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents

1 reference

https://api.crossref.org/works/10.1007%2FS00280-009-0987-8

21 January 2018

Identifiers

10.1007/S00280-009-0987-8

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39869117&oldid=2091787979"